7.5 semaglutide | NextGenRx Compound Pharmacy GLP-1 Genetics: How Genes Affect

Ideal candidates for Klinic-guided medical weight loss are adults with a BMI of 30 or more, or a BMI of 27 alongside weight-linked conditions

We therefore conclude that before the place of GLP-1/glucagon co-agonists within the therapeutic armamentarium can be defined, future research efforts need to address the following outstanding questions: What is the optimal balance and receptor potency of GLP-1 and glucagon in a long-acting co-agonist, to minimise adverse effects and to optimise efficacy ( Figure 2 )

If approved, you receive a personalized treatment plan, including medication from FDA-registered and inspected pharmacies, necessary lab work, and unlimited support

This helps maintain healthy skin at the injection sites